SYNGENE INTERNATIONAL LTDSYNGENE INTERNATIONAL LTDSYNGENE INTERNATIONAL LTD

SYNGENE INTERNATIONAL LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪361.38 B‬INR
12.00INR
‪5.10 B‬INR
‪34.85 B‬INR
‪180.79 M‬
Beta (1Y)
0.31
Employees (FY)
‪8.15 K‬
Change (1Y)
‪+1.3 K‬ +18.97%
Revenue / Employee (1Y)
‪51.30 K‬INR
Net income / Employee (1Y)
‪7.51 K‬INR

About SYNGENE INTERNATIONAL LTD


CEO
Jonathan Hunt
Headquarters
Bangalore
Founded
1993
ISIN
INE398R01022
FIGI
BBG008KWGR11
Syngene International Ltd. operates as a global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries. It is engaged providing contract research and manufacturing services. The firm’s services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SYNGENE is 898.45 INR — it has decreased by −1.65% in the past 24 hours. Watch SYNGENE INTERNATIONAL LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SYNGENE INTERNATIONAL LTD stocks are traded under the ticker SYNGENE.
SYNGENE stock has risen by 4.23% compared to the previous week, the month change is a 2.32% rise, over the last year SYNGENE INTERNATIONAL LTD has showed a 23.94% increase.
We've gathered analysts' opinions on SYNGENE INTERNATIONAL LTD future price: according to them, SYNGENE price has a max estimate of 1,060.00 INR and a min estimate of 700.00 INR. Watch SYNGENE chart and read a more detailed SYNGENE INTERNATIONAL LTD stock forecast: see what analysts think of SYNGENE INTERNATIONAL LTD and suggest that you do with its stocks.
SYNGENE reached its all-time high on Sep 16, 2024 with the price of 945.25 INR, and its all-time low was 147.50 INR and was reached on Aug 11, 2015. View more price dynamics on SYNGENE chart.
See other stocks reaching their highest and lowest prices.
SYNGENE stock is 2.87% volatile and has beta coefficient of 0.31. Track SYNGENE INTERNATIONAL LTD stock price on the chart and check out the list of the most volatile stocks — is SYNGENE INTERNATIONAL LTD there?
Today SYNGENE INTERNATIONAL LTD has the market capitalization of ‪360.26 B‬, it has decreased by −1.87% over the last week.
Yes, you can track SYNGENE INTERNATIONAL LTD financials in yearly and quarterly reports right on TradingView.
SYNGENE INTERNATIONAL LTD is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
SYNGENE earnings for the last quarter are 2.60 INR per share, whereas the estimation was 2.70 INR resulting in a −3.60% surprise. The estimated earnings for the next quarter are 3.36 INR per share. See more details about SYNGENE INTERNATIONAL LTD earnings.
SYNGENE INTERNATIONAL LTD revenue for the last quarter amounts to ‪8.91 B‬ INR, despite the estimated figure of ‪8.83 B‬ INR. In the next quarter, revenue is expected to reach ‪9.46 B‬ INR.
SYNGENE net income for the last quarter is ‪1.06 B‬ INR, while the quarter before that showed ‪757.00 M‬ INR of net income which accounts for 40.16% change. Track more SYNGENE INTERNATIONAL LTD financial stats to get the full picture.
Yes, SYNGENE dividends are paid annually. The last dividend per share was 1.25 INR. As of today, Dividend Yield (TTM)% is 0.14%. Tracking SYNGENE INTERNATIONAL LTD dividends might help you take more informed decisions.
SYNGENE INTERNATIONAL LTD dividend yield was 0.18% in 2023, and payout ratio reached 9.84%. The year before the numbers were 0.08% and 4.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has ‪8.15 K‬ employees. See our rating of the largest employees — is SYNGENE INTERNATIONAL LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNGENE INTERNATIONAL LTD EBITDA is ‪9.84 B‬ INR, and current EBITDA margin is 31.06%. See more stats in SYNGENE INTERNATIONAL LTD financial statements.
Like other stocks, SYNGENE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNGENE INTERNATIONAL LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNGENE INTERNATIONAL LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNGENE INTERNATIONAL LTD stock shows the buy signal. See more of SYNGENE INTERNATIONAL LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.